SCHEMBL1627352

SCHEMBL1627352

[N]C1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2966758 1.00 ALDH1A1 (0.36)
SCHEMBL2974309 1.00 ALDH1A1 (0.36)
SCHEMBL2972497 1.00 ALDH1A1 (0.36)
SCHEMBL218305 1.00
SCHEMBL2971655 1.00 ALDH1A1 (0.36)
SCHEMBL2974460 1.00
SCHEMBL2970770 1.00 ALDH1A1 (0.36)
SCHEMBL2962379 1.00 ALDH1A1 (0.36)
SCHEMBL2972603 1.00 ALDH1A1 (0.36)
SCHEMBL1797081 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113651836-B Organic compound and organic electroluminescent device containing same 清华大学 2023-05-12 CN claimed
CN-111943949-B Organic compound, application thereof and organic electroluminescent device containing compound 清华大学 2022-05-20 CN claimed
CN-111943949-A Organic compound, application thereof and organic electroluminescent device containing organic compound 清华大学 2020-11-17 CN claimed
CN-113651836-B Organic compound and organic electroluminescent device containing same 清华大学 2023-05-12 CN disclosed
CN-111943949-B Organic compound, application thereof and organic electroluminescent device containing compound 清华大学 2022-05-20 CN disclosed
CN-111943949-A Organic compound, application thereof and organic electroluminescent device containing organic compound 清华大学 2020-11-17 CN disclosed
CN-110746425-A Novel organic compound and application thereof 清华大学 2020-02-04 CN disclosed
EP-1794129-B1 Synthesis by chiral diamine-mediated asymmetric alkylation JANSSEN PHARMACEUTICA NV (BE) 2015-12-30 EP disclosed
US-20140179924-A1 Process for the preparation of cathepsin S inhibitors JANSSEN PHARMACEUTICA NV (US) 2014-06-26 US disclosed
EP-1737297-B1 IMIDAZOLE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2012-12-19 EP disclosed
US-8242275-B2 Bicyclic pyrazole compounds as antibacterial agents JANSSEN PHARMACEUTICA NV (BE) 2012-08-14 US disclosed
US-6635633-B2 Substituted pyrazoles ORTHO-PHARMACEUTICAL, INC. 2003-10-21 US disclosed
US-20030176438-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines ORTHOMCNEIL PHARMACEUTICAL, INC. 2003-09-18 US disclosed
US-6583155-B2 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-24 US disclosed
US-6579896-B2 Immunology response; autoimmune disease ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-17 US disclosed
US-20030073672-A1 Method for treating allergies using substituted pyrazoles ORTHO MCNEIL PHARMACEUTICAL, INC. 2003-04-17 US disclosed
EP-1201235-A1 NEUROPATHY IMPROVERS CONTAINING NITROGENOUS COMPOUNDS AS THE ACTIVE INGREDIENT TEIJIN LIMITED (JP) 2002-05-02 EP disclosed
US-20020040019-A1 Substituted pyrazoles ORTHO MCNEIL PHARMACEUTICAL, INC. 2002-04-04 US disclosed
US-20020006934-A1 Phenyl-substituted imidazopyridines ORTHO MCNEIL PHARMACEUTICAL, INC. 2002-01-17 US disclosed
US-20010051632-A1 Phenyl-substituted indolizines and tetrahydroindolizines ORTHO MCNEIL PHARMACEUTICAL, INC. 2001-12-13 US disclosed